Ticker brief
HALO
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
15
authors 14d
12
crowd 14d
+0.2σ
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-10-07 → 2026-10-16 · now +0.40 (−1 bearish … +1 bullish)
Who spoke12
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @thesetupfactory | B | -2.36 | 3 | +0.33 |
| @Quantumup1 | C | +0.10 | 2 | +0.40 |
| @fwpharma | B | -1.91 | 1 | +0.15 |
| @OzmosiHealth | C | · | 1 | +0.40 |
| @newsinvesting | C | · | 1 | +0.50 |
| @AlexMarenco1 | C | -1.18 | 1 | +0.10 |
| @cfromhertz | B | -0.96 | 1 | +0.40 |
| @ivanhoff | C | -1.07 | 1 | +0.35 |
| @HedgeFundTips | B | +0.73 | 1 | +0.10 |
| @ThePupOfWallSt | C | -1.47 | 1 | +0.55 |
| @OptionsHawk | B | -1.11 | 1 | +0.70 |
| @equitydd | C | -1.08 | 1 | +0.35 |
Recent signals15of 15 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-16 | @Quantumup1 | +0.40 | H.C. Wainwright reiterated Buy on Halozyme with a $130 target and cited potential royalty expansion. | · | tweet ↗ |
| 2026-10-15 | @thesetupfactory | +0.30 | Lists liquid stocks making new relative-strength highs near their 52-week highs. | · | tweet ↗ |
| 2026-10-15 | @thesetupfactory | +0.35 | Uses new thematic relative-strength highs to identify leadership and capital flows into non-growth stocks. | · | tweet ↗ |
| 2026-10-15 | @thesetupfactory | +0.35 | Identifies non-growth leadership through stocks reaching new relative-strength highs. | · | tweet ↗ |
| 2026-10-14 | @equitydd | +0.35 | Lists stocks reaching new all-time highs. | · | tweet ↗ |
| 2026-10-14 | @OptionsHawk | +0.70 | Briefly praises HALO while citing a chart. | · | tweet ↗ |
| 2026-10-14 | @ThePupOfWallSt | +0.55 | Reports HALO breaking out amid biotechnology strength. | · | tweet ↗ |
| 2026-10-14 | @HedgeFundTips | +0.10 | Presents a broad list of names receiving money flows today; output is capped at six tickers. | · | tweet ↗ |
| 2026-10-14 | @ivanhoff | +0.35 | Several biotechs are reaching 52-week relative-strength highs versus SPY. | · | tweet ↗ |
| 2026-10-14 | @cfromhertz | +0.40 | Reports a strong start to the session for HALO. | · | tweet ↗ |
| 2026-10-13 | @Quantumup1 | +0.40 | H.C. Wainwright reiterated HALO Buy with a $130 target after an FDA approval. | · | tweet ↗ |
| 2026-10-07 | @AlexMarenco1 | +0.10 | Flags HALO as an institutional-buying name, with details dependent on linked media. | · | tweet ↗ |
| 2026-10-07 | @newsinvesting | +0.50 | A Dutch court granted Halozyme an injunction blocking Merck's Keytruda SC in eight markets. | · | tweet ↗ |
| 2026-10-07 | @OzmosiHealth | +0.40 | Reports Halozyme winning an injunction blocking Keytruda SC manufacture and sale in Europe. | · | tweet ↗ |
| 2026-10-07 | @fwpharma | +0.15 | A court orders Merck to halt Keytruda SC sales in multiple EU countries. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.